Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by robertshawon Apr 08, 2022 6:58am
176 Views
Post# 34586972

RE:RE:RE:RE:RE:Flawed Data Presenation

RE:RE:RE:RE:RE:Flawed Data Presenation
Infinity wrote: Yes the durability is consistent which is great.  Data can be presented in many ways, but the purpose of the presentation does not change, the purpose is to make it clear to the readers.  That clarity has not been achieved which is fairly easy to correct.
The other point on my earlier messsage on the U.S clinical study sites seem to exist in name only with really no clinical study being done.  Some of the clinical study sites do not even offer PDT as an option for NMIBC on their web page.  They are not even trying to get to enlist patients, It appears that some of the clinical study centers are not genuinely interested.  No question it is a PDT an established treatent,  TLD 1433 designed by sherri is a fabulous product that is in the wrong hands to develop.


"TLD 1433 designed by sherri is a fabulous product that is in the wrong hands to develop.", well said, completely agree... Best technology, yet ruined by idiots...
<< Previous
Bullboard Posts
Next >>